Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of five years of patients continuously treated with SYFOVRE (pegcetacoplan ...

A study reveals that cryopreserved amniotic membrane enhances recovery and reduces infection risk in post-corneal ...

Second-year medical student Rishika Garg shares insights from a nationwide analysis revealing inconsistencies in ...

Paul Badawi, Founder and CEO of Sight Sciences and Leon Herndon, MD, Duke University Eye Center, Durham, NC, commented on the ...

Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving ...

Inder Paul Singh, a glaucoma anterior segment surgeon from southeastern Wisconsin, presented his clinical experience and a ...

In the study, authors investigated the natural history of GA lesion incidence rates and analyzed potential risk factors for faster incidence of GA lesions.

At AAO 2025, David Eichenbaum, Director of Research and partner at Retina Vitreous Associates of Florida, and collaborative ...

OCT has transformed retinal practice, enhancing diagnostic accuracy and treatment efficiency while reducing reliance on ...

SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...

Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...

Allison Soneru, MD, is with theglaucoma service, Mass Eye and Ear; instructor, Ophthalmology, Harvard Medical School; associate director, Anterior Segment Fellowship, Mass Eye and Ear; and glaucoma ...